Adopted sister Kelly locks biological heiress Clara inside a high-security mental asylum for three brutal years, embezzling Clara's multi-billion-dollar biotech inheritance. Everyone believes Clara has been driven mad by heavy medication, but the brilliant scientist spent her confinement designing breakthrough quantum genetic computing algorithms on scraps of paper. Escaping with the help of a loyal doctor, Clara returns to Boston high society just as Kelly prepares to sell the family's proprietary cancer patents to foreign syndicates. Crashing the corporate symposium, Clara connects her quantum computing drive to the main servers, instantly exposing Kelly's falsified clinical trial results, stolen research, and fraudulent medical credentials before stunned investors. Panicked shareholders cancel their contracts on the spot, while the board of directors unanimously reinstates Clara as supreme chief executive officer. When a cornered and disgraced Kelly attempts to inject Clara with a lethal neurotoxin in the parking garage, will Clara's automated security defenses neutralize the imposter forever?